found that, through bioinformatics analysis, elevated USP39 expression was predictive of poor prognosis in patients with pancreatic ductal adenocarcinoma and was closely linked to various clinicopathological features, including tumor differentiation and immune infiltration levels (32). This evidence concerns the gene USP39 and pancreatic ductal adenocarcinoma.